Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors

Rongjun He, Zhi Hong Yu, Ruo Yu Zhang, Li Wu, Andrea M. Gunawan, Brandon S. Lane, Joong S. Shim, Li Fan Zeng, Yantao He, Lan Chen, Clark Wells, Jun O. Liu, Zhong-Yin Zhang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Protein tyrosine phosphatases (PTPs) are potential therapeutic targets for many diseases. Unfortunately, despite considerable drug discovery efforts devoted to PTPs, obtaining selective and cell permeable PTP inhibitors remains highly challenging. We describe a strategy to explore the existing drug space for previously unknown PTP inhibitory activities. This led to the discovery of cefsulodin as an inhibitor of SHP2, an oncogenic phosphatase in the PTP family. Crystal structure analysis of SHP2 interaction with cefsulodin identified sulfophenyl acetic amide (SPAA) as a novel phosphotyrosine (pTyr) mimetic. A structure-guided and SPAA fragment-based focused library approach produced several potent and selective SHP2 inhibitors. Notably, these inhibitors blocked SHP2-mediated signaling events and proliferation in several cancer cell lines. Thus, SPAA may serve as a new platform for developing chemical probes for other PTPs.

Original languageEnglish
Pages (from-to)782-786
Number of pages5
JournalACS Medicinal Chemistry Letters
Volume6
Issue number7
DOIs
StatePublished - Jul 9 2015

Fingerprint

Phosphotyrosine
Protein Tyrosine Phosphatases
Cefsulodin
Amides
Acetic Acid
Pharmaceutical Preparations
Non-Receptor Type 11 Protein Tyrosine Phosphatase
Drug Discovery
Phosphoric Monoester Hydrolases
Libraries
Crystal structure
Cells
Cell Line
Neoplasms

Keywords

  • anticancer agents
  • fragment-based library
  • Protein tyrosine phosphatase
  • pTyr mimetics
  • SHP2 inhibitors

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery
  • Biochemistry

Cite this

Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors. / He, Rongjun; Yu, Zhi Hong; Zhang, Ruo Yu; Wu, Li; Gunawan, Andrea M.; Lane, Brandon S.; Shim, Joong S.; Zeng, Li Fan; He, Yantao; Chen, Lan; Wells, Clark; Liu, Jun O.; Zhang, Zhong-Yin.

In: ACS Medicinal Chemistry Letters, Vol. 6, No. 7, 09.07.2015, p. 782-786.

Research output: Contribution to journalArticle

He, R, Yu, ZH, Zhang, RY, Wu, L, Gunawan, AM, Lane, BS, Shim, JS, Zeng, LF, He, Y, Chen, L, Wells, C, Liu, JO & Zhang, Z-Y 2015, 'Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors', ACS Medicinal Chemistry Letters, vol. 6, no. 7, pp. 782-786. https://doi.org/10.1021/acsmedchemlett.5b00118
He, Rongjun ; Yu, Zhi Hong ; Zhang, Ruo Yu ; Wu, Li ; Gunawan, Andrea M. ; Lane, Brandon S. ; Shim, Joong S. ; Zeng, Li Fan ; He, Yantao ; Chen, Lan ; Wells, Clark ; Liu, Jun O. ; Zhang, Zhong-Yin. / Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors. In: ACS Medicinal Chemistry Letters. 2015 ; Vol. 6, No. 7. pp. 782-786.
@article{5a44e2c40470451183af3c245cc7fc05,
title = "Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors",
abstract = "Protein tyrosine phosphatases (PTPs) are potential therapeutic targets for many diseases. Unfortunately, despite considerable drug discovery efforts devoted to PTPs, obtaining selective and cell permeable PTP inhibitors remains highly challenging. We describe a strategy to explore the existing drug space for previously unknown PTP inhibitory activities. This led to the discovery of cefsulodin as an inhibitor of SHP2, an oncogenic phosphatase in the PTP family. Crystal structure analysis of SHP2 interaction with cefsulodin identified sulfophenyl acetic amide (SPAA) as a novel phosphotyrosine (pTyr) mimetic. A structure-guided and SPAA fragment-based focused library approach produced several potent and selective SHP2 inhibitors. Notably, these inhibitors blocked SHP2-mediated signaling events and proliferation in several cancer cell lines. Thus, SPAA may serve as a new platform for developing chemical probes for other PTPs.",
keywords = "anticancer agents, fragment-based library, Protein tyrosine phosphatase, pTyr mimetics, SHP2 inhibitors",
author = "Rongjun He and Yu, {Zhi Hong} and Zhang, {Ruo Yu} and Li Wu and Gunawan, {Andrea M.} and Lane, {Brandon S.} and Shim, {Joong S.} and Zeng, {Li Fan} and Yantao He and Lan Chen and Clark Wells and Liu, {Jun O.} and Zhong-Yin Zhang",
year = "2015",
month = "7",
day = "9",
doi = "10.1021/acsmedchemlett.5b00118",
language = "English",
volume = "6",
pages = "782--786",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors

AU - He, Rongjun

AU - Yu, Zhi Hong

AU - Zhang, Ruo Yu

AU - Wu, Li

AU - Gunawan, Andrea M.

AU - Lane, Brandon S.

AU - Shim, Joong S.

AU - Zeng, Li Fan

AU - He, Yantao

AU - Chen, Lan

AU - Wells, Clark

AU - Liu, Jun O.

AU - Zhang, Zhong-Yin

PY - 2015/7/9

Y1 - 2015/7/9

N2 - Protein tyrosine phosphatases (PTPs) are potential therapeutic targets for many diseases. Unfortunately, despite considerable drug discovery efforts devoted to PTPs, obtaining selective and cell permeable PTP inhibitors remains highly challenging. We describe a strategy to explore the existing drug space for previously unknown PTP inhibitory activities. This led to the discovery of cefsulodin as an inhibitor of SHP2, an oncogenic phosphatase in the PTP family. Crystal structure analysis of SHP2 interaction with cefsulodin identified sulfophenyl acetic amide (SPAA) as a novel phosphotyrosine (pTyr) mimetic. A structure-guided and SPAA fragment-based focused library approach produced several potent and selective SHP2 inhibitors. Notably, these inhibitors blocked SHP2-mediated signaling events and proliferation in several cancer cell lines. Thus, SPAA may serve as a new platform for developing chemical probes for other PTPs.

AB - Protein tyrosine phosphatases (PTPs) are potential therapeutic targets for many diseases. Unfortunately, despite considerable drug discovery efforts devoted to PTPs, obtaining selective and cell permeable PTP inhibitors remains highly challenging. We describe a strategy to explore the existing drug space for previously unknown PTP inhibitory activities. This led to the discovery of cefsulodin as an inhibitor of SHP2, an oncogenic phosphatase in the PTP family. Crystal structure analysis of SHP2 interaction with cefsulodin identified sulfophenyl acetic amide (SPAA) as a novel phosphotyrosine (pTyr) mimetic. A structure-guided and SPAA fragment-based focused library approach produced several potent and selective SHP2 inhibitors. Notably, these inhibitors blocked SHP2-mediated signaling events and proliferation in several cancer cell lines. Thus, SPAA may serve as a new platform for developing chemical probes for other PTPs.

KW - anticancer agents

KW - fragment-based library

KW - Protein tyrosine phosphatase

KW - pTyr mimetics

KW - SHP2 inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84936861995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936861995&partnerID=8YFLogxK

U2 - 10.1021/acsmedchemlett.5b00118

DO - 10.1021/acsmedchemlett.5b00118

M3 - Article

VL - 6

SP - 782

EP - 786

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 7

ER -